Environmental risk assessment of pharmaceuticals in rivers: Relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain)

Environment International

Volumn 36, Issue 2, 2010, Pages 153-162

  Ginebreda, Antoni ^a   Muñoz, Isabel ^b   de Alda, Miren López ^a   Brix, Rikke ^a   López Doval, Julio ^b   Barceló, Damià ^a,c  

^a INSTITUTE OF ENVIRONMENTAL ASSESSMENT AND WATER RESEARCH   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c UNIVERSITY OF GIRONA   (Spain)

Author keywords

Aquatic macroinvertebrates; Diversity indexes; Hazard quotients; Llobregat River; Pharmaceuticals; Risk assessment

Indexed keywords

ALGAE; ANTIBIOTICS; AQUATIC ECOSYSTEMS; BIOACTIVITY; BIOASSAY; BIOHAZARDS; BIOLOGICAL WATER TREATMENT; DRUG PRODUCTS; FISH; HAZARDS; RISK ASSESSMENT; TOXICITY; WASTEWATER TREATMENT;

AQUATIC MACROINVERTEBRATES; DIVERSITY INDEXES; ENVIRONMENTAL RISK ASSESSMENT; HAZARD QUOTIENTS; LLOBREGAT RIVER; MACROINVERTEBRATE COMMUNITY; MACROINVERTEBRATE DIVERSITIES; WASTEWATER TREATMENT SYSTEM;

RIVERS;

ATENOLOL; AZITHROMYCIN; BEZAFIBRATE; CARBAMAZEPINE; CLOFIBRIC ACID; COMPACTIN; DICLOFENAC; ERYTHROMYCIN; FAMOTIDINE; FLUOXETINE; GEMFIBROZIL; IBUPROFEN; INDOMETACIN; KETOPROFEN; LANSOPRAZOLE; LORATADINE; MEFENAMIC ACID; METOPROLOL; NAPROXEN; OFLOXACIN; PARACETAMOL; PAROXETINE; PRAVASTATIN; PROPRANOLOL; PROPYPHENAZONE; RANITIDINE; SOTALOL; SULFAMETHOXAZOLE; TRIMETHOPRIM;

AQUATIC ECOSYSTEM; DIVERSITY INDEX; DRUG; ENVIRONMENTAL RISK; MACROINVERTEBRATE; POLLUTION EFFECT; RISK ASSESSMENT; RIVER WATER; WATER POLLUTION;

ALGA; ARTICLE; BIOASSAY; BIODIVERSITY; BIOMASS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DAPHNIA; DENSITY; ENVIRONMENTAL IMPACT ASSESSMENT; FISH; GEOGRAPHY; HAZARD ASSESSMENT; MACROINVERTEBRATE; NONHUMAN; ORGANISM COMMUNITY; PRIORITY JOURNAL; RIVER; SENSITIVITY ANALYSIS; SPAIN; WATER ANALYSIS; WATER POLLUTION;

CATALONIA; LLOBREGAT RIVER; SPAIN;

ALGAE; DAPHNIA;

EID: 73249146532     PISSN: 01604120     EISSN: 18736750     Source Type: Journal    
DOI: 10.1016/j.envint.2009.10.003     Document Type: Article

References (54)

1. Alonso M.C., Tirapu L., Ginebreda A., and Barceló D. Monitoring and toxicity of sulfonated derivatives of benzene and naphthalene in municipal sewage treatment plants. Environ Pollut 137 2 (2005) 253-262
2. Benke A.C., Huryn A.D., Smock L.A., and Wallace J.B. Length-mass relationships for freshwater macroinvertebrates in North America with particular reference to the southeastern United States. J North Am Benthol Soc 18 (1999) 308-343
3. Bound J.P., and Voulvoulis N. Predicted and measured concentrations for selected pharmaceuticals in UK rivers: implications for risk assessment. Water Res 40 (2006) 2885-2892
4. Brix, R., Postigo, C., Gonzalez, S., Villagrasa, M., Navarro, A., Kuster, M. et al., Analysis and occurrence of alkylphenolic compounds and estrogens in a European river basin and their role as priority pollutants. Anal Bioanal Chem (submitted for publication).
5. Carballa M., Omil F., and Lema J.M. Removal of cosmetic ingredients and pharmaceuticals in sewage primary treatment. Water Res 39 (2005) 4790-4796
6. Castiglioni S., Fanelli R., Calamari D., Bagnati R., and Zuccato E. Methodological approaches for studying pharmaceuticals in the environment by comparing predicted and measured concentrations in River Po, Italy. Regul Toxicol Pharmacol 39 (2004) 25-32
7. Céspedes R., Lacorte S., Raldúa D., Ginebreda A., Barceló D., and Piña B. Distribution of endocrine disruptors in the Llobregat River Basin (Catalonia, N.E. Spain). Chemosphere 61 (2005) 1710-1719
8. Cleuvers M. Aquatic ecotoxicity of pharmaceuticals including the assessment of combination effects. Toxicol Lett 142 (2003) 185-194
9. Cleuvers M. Mixture toxicity of the anti-inflammatory drugs diclofenac, ibuprofen, naproxen and acetylsalicylic acid. Ecotoxicol Environ Saf 59 (2004) 309-315
10. Comoretto L., and Chiron S. Comparing pharmaceutical and pesticide loads into a small Mediterranean river. Sci Total Environ 349 (2005) 201-210
11. Cooper E.R., Siewicki T.C., and Phillips K. Preliminary risk assessment database and risk ranking of pharmaceuticals in the environment. Sci Total Environ 398 (2008) 26-33
12. Crane M., Watts C., and Boucard T. Chronic aquatic environmental risks from exposure to human pharmaceuticals. Sci Total Environ 367 (2006) 23-41
13. Daughton C.G., and Ternes T.A. Pharmaceuticals and personal care products in the environment: agents of subtle change?. Environ Health Perspect 107 (1999) 907-938
14. EMEA European Agency for the Evaluation of Medicinal Products .Draft CPMP Discussion Paper on environmental risk assessment of Non-genetically Modified Organisms (Non-GMO) containing medicinal products for human use 2001, CMP/SWP/4447/00 Final; EMEA London.
15. Escher B.I., Bramaz N., Eggen R.I.L., and Richter M. In vitro assessment of models toxic action of pharmaceuticals in aquatic life. Environ Sci Technol 39 (2005) 3090-3100
16. Farré M., Ferrer I., Ginebreda A., Figueras M., Olivella L., Tirapu L., et al. Determination of drugs in surface water and wastewater samples by liquid chromatography-mass spectrometry: methods and preliminary results including toxicity studies with Vibrio fischeri. J Chromatogr 938 (2001) 187-197
17. Fent K., Weston A.A., and Caminada D. Ecotoxicology of human pharmaceuticals. Aquat Toxicol 76 (2006) 122-159
18. Gros M., Petrovic M., and Barceló D. Development of a multi-residue analytical methodology based on liquid chromatography-tandem mass spectrometry (LC-MS/MS) for screening and trace level determination of pharmaceuticals in surface and wastewaters. Talanta 70 (2006) 678-690
19. Gros M., Petrovic M., and Barceló D. Multi-residue analytical methods using LC-tandem MS for the determination of pharmaceuticals in environmental and wastewater samples: a review. Anal Bioanal Chem 386 (2006) 941-952
20. Gros M., Petrovic M., and Barceló D. Wastewater treatment plants as a pathway for aquatic contamination by pharmaceuticals in the Ebro river basin (northeast Spain). Environ Toxicol Chem 26 (2007) 1553-1562
21. Gros M., Petrovic M., and Barceló D. Tracing pharmaceutical residues of different therapeutic classes in environmental waters by using liquid chromatography/quadrupole-linear ion trap mass spectrometry and automated library searching. Anal Chem 81 (2009) 898-912
22. Gros M., Petrovic M., Ginebreda A., and Barceló D. Removal of pharmaceuticals during wastewater treatment and environmental risk assessment using hazard indexes. Environ Int 36 (2009) 15-26
23. Grung M., Kallqvist T., Sakshaug S., Skurtveit S., and Thomas K.V. Environmental assessment of Norwegian priority pharmaceuticals based on the EMEA guideline. Ecotoxicol Environ Saf 71 (2008) 328-340
24. Heberer T., Reddersen K., and Mechlinski A. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci Technol 46 (2002) 81-88
25. Henry T.B., Kwon J.W., Armbrust K.L., and Black M.C. Acute and chronic toxicity of five selective serotonin reuptake inhibitors in Ceriodaphnia dubia. Environ Toxicol Chem 23 (2004) 2229-2233
26. Hernando M.D., Mezcua M., Fernandez-Alba A.R., and Barceló D. Environmental risk assessment of pharmaceutical residues in wastewater effluents, surface waters and sediments. Talanta 69 (2006) 334-342
27. Hernando M.D., Aguera A., and Fernandez-Alba A.R. LC-MS analysis and environmental risk of lipid regulators. Anal Bioanal Chem 387 (2007) 1269-1285
28. Huschek G., Hansen P.D., Maurer H.H., Krengel D., and Kayser A. Environmental risk assessment of medicinal products for human use according to European Commission recommendations. Environ Toxicol 19 (2004) 226-240
29. Isidori M., Lavorgna M., Nardelli A., Pascarella L., and Parrella A. Toxic and genotoxic evaluation of six antibiotics on non-target organisms. Sci Total Environ 346 (2005) 87-98
30. Joss A., Keller E., Alder A.C., Gobel A., McArdell C.S., Ternes T., et al. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res 39 (2005) 3139-3152
31. Kim Y., Choi K., Jung J., Park S., Kim P.G., and Park J. Aquatic toxicity of acetaminophen, carbamazepine, cimetidine, diltiazem and six major sulfonamides, and their potential ecological risks in Korea. Environ Int 33 (2007) 370-375
32. Kolpin D.W., Skopec M., Meyer M.T., Furlong E.T., and Zaugg S.D. Urban contribution of pharmaceuticals and other organic wastewater contaminants to streams during different flow conditions. Sci Total Environ 328 (2004) 119-130
33. Kuster M., López de Alda M.J., Hernando M.D., Petrovic M., Martín-Alonso J., and Barceló D. Analysis and occurrence of pharmaceuticals, estrogens, progestogens and polar pesticides in sewage treatment plant effluents, river water and drinking water in the Llobregat river basin (Barcelona, Spain). J Hydrol 358 (2008) 112-123
34. Lee Y.J., Lee S.E., Lee D.S., and Kim Y.H. Risk assessment of human antibiotics in Korean aquatic environment. Environ Toxicol Pharmacol 26 (2008) 216-221
35. Margalef R. Teoría de los sistemas ecológicos (1991), Publicacions de la Universitat de Barcelona, Barcelona 92-93
36. Martínez Bueno M.J., Aguera A., Gómez M.J., Hernando M.D., García Reyes J.F., and Fernández Alba A.R. Application of liquid chromatography/quadrupole-linear ion trap mass spectrometry and time-of-flight mass spectrometry to the determination of pharmaceuticals and related contaminants in wastewater. Anal Chem 79 (2007) 9372-9384
37. Muñoz, I, López-Doval, J, Ricart, M, Villagrassa, M, Brix, R, Geiszinger, A. et al., Bridging levels of pharmaceuticals in river water with biological community structure in the Llobregat River basin (NE Spain). Environ Toxicol Chem (in press), doi:10.1897/08-486.1.
38. Nunes B., Carvalho F., and Guilhermino L. Acute toxicity of widely used pharmaceuticals in aquatic species: Gambusia holbrooki, Artemia parthenogenetica and Tetraselmis chuii. Ecotoxicol Environ Saf 61 (2005) 413-419
39. Pascoe D., Karntanut W., and Muller C.T. Do pharmaceuticals affect freshwater invertebrates? A study with the cnidarian Hydra vulgaris. Chemosphere 51 (2003) 521-528
40. Petrovic M., Hernando M.D., Díaz-Cruz M.S., and Barceló D. Liquid chromatography-tandem mass spectrometry for the analysis of pharmaceutical residues in environmental samples: a review. J Chromatogr 1067 (2005) 1-14
41. Petrovic M., Gros M., and Barceló D. Multi-residue analysis of pharmaceuticals in wastewater by mass spectrometry. J Chromatogr 1124 (2006) 68-81
42. Pomati F., Orlandi C., Clerici M., Luciani F., and Zuccato E. Effects and interactions in an environmentally relevant mixture of pharmaceuticals. Toxicol Sci 102 (2008) 129-137
43. Quinn B., Gagne F., and Blaise C. The effects of pharmaceuticals on the regeneration of the cnidarian, Hydra attenuata. Sci Total Environ 402 (2008) 62-69
44. Radjenovic J., Petrovic M., and Barceló D. Analysis of pharmaceuticals in wastewater and removal using a membrane bioreactor. Anal Bioanal Chem 387 (2007) 1365-1377
45. Ricart, M, Guasch, H, Barceló, D, Brix, R, Conceição, MH, Geiszinger, A. et al., Primary and complex stressors in polluted Mediterranean rivers: pesticide effects on biological communities. J Hydrol in press. doi:10.1016/j.hydrol.2009.08.014.
46. Richards S.M., Wilson C.J., Johnson D.J., Castle D.M., Lam M., Mabury S.A., et al. Effects of pharmaceutical mixtures in aquatic microcosms. Environ Toxicol Chem 23 (2004) 1035-1042
47. Sanderson H., Johnson D.J., Wilson C.J., Brain R.A., and Solomon K.R. Probabilistic hazard assessment of environmentally occurring pharmaceuticals toxicity to fish, daphnids and algae by ECOSAR screening. Toxicol Lett 144 (2003) 383-395
48. Sanderson H., Johnson D.J., Reitsma T., Brain R.A., Wilson C.J., and Solomon K.R. Ranking and prioritization of environmental risks of pharmaceuticals in surface waters. Regul Toxicol Pharmacol 39 (2004) 158-183
49. Santos J.L., Aparicio I., and Alonso E. Occurrence and risk assessment of pharmaceutically active compounds in wastewater treatment plants. A case study: Seville city (Spain). Environ Int 33 (2007) 596-601
50. Stauer-Lauridsen F., Birkved M., Hansen L.P., Holten Lützhoft H.C., and Halling-Sorensen B. Environmental risk assessment of human pharmaceuticals in Denmark after normal therapeutic use. Chemosphere 40 (2000) 783-793
51. Straub J.O. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001. Toxicol Lett 131 (2002) 137-143
52. Suárez S., Carballa M., Omil F., and Lema J.M. How are pharmaceutical and personal care products (PPCPs) removed from urban wastewaters?. Rev Environ Sci Biotechnol 7 (2008) 125-138
53. Vieno N., Tuhkanen T., and Kronberg L. Elimination of pharmaceuticals in sewage treatment plants in Finland. Water Res 41 (2007) 1001-1012
54. Von der Ohe P.C., De Deckere E., Prüß A., Muñoz I., Wolfram G., Villagrassa M., et al. Towards an integrated risk assessment of the ecological and chemical status of European river basins. Integr Environ Assess Manag 5 1 (2009) 50-61